Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


ResMed reported $1.58B in Loan Capital for its fiscal quarter ending in March of 2023.

Loan Capital Change
Ansell ANN:AU USD 473.8M 6.2M
Artivion Inc CRY:US USD 309.86M 282K
Baxter International BAX:US USD 15.28B 46M
Cochlear COH:AU AUD 214M 38.8M
Cooper Companies COO:US USD 2.57B 61.6M
CSL CSL:AU USD 10.9B 5.74B
Dexcom DXCM:US USD 1.26B 400K
Edwards Lifesciences EW:US USD 596.5M 200K
Estia Health EHE:AU AUD 152.1M 5.15M
Fisher Paykel Healthcare FPH:NZ NZD 124.5M 14.1M
Haemonetics HAE:US USD 754.1M 2.72M
Hologic HOLX:US USD 2.81B 9.2M
Idexx Laboratories IDXX:US USD 696.36M 1.98M
Insulet PODD:US USD 1.37B 5.5M
Integra LifeSciences IART:US USD 1.44B 34.52M
Masimo MASI:US USD 897.5M 44.1M
NuVasive NUVA:US USD 445.84M 765K
Ramsay Health Care RHC:AU AUD 10.97B 664.7M
ResMed RMD:US USD 1.58B 214.73M
Sigma Healthcare Ltd SIG:AU AUD 214.04M 17.46M
Sonic Healthcare SHL:AU AUD 2.69B 20.44M
Steris STE:US USD 3.02B 17.08M
Teleflex TFX:US USD 1.55B 74.55M
Thermo Fisher Scientific TMO:US USD 29.14B 226M